Oral Tetracyclines for Ocular Rosacea: An Evidence-Based Review of the Literature

Cornea

Volumn 23, Issue 1, 2004, Pages 106-109

  Stone, Donald U ^a   Chodosh, James ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Clinical trials; Doxycycline; Rosacea; Tetracycline

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; OXYTETRACYCLINE; PLACEBO; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EYE DISEASE; HUMAN; MEDICAL LITERATURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; ROSACEA; SHORT SURVEY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; EYE DISEASES; HUMANS; RANDOMIZED CONTROLLED TRIALS; ROSACEA; TETRACYCLINES;

EID: 0346788523     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200401000-00020     Document Type: Short Survey

References (32)

1. Tolman EL. Acne and acneiform dermatoses. In: Moschella SL, Hurley HJ, eds. Dermatology, vol. 2. Philadelphia: WB Saunders, 1992:1477-1492.
2. Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol. 1986;31:145-158.
3. Sneddon IB. A clinical trial of tetracycline in rosacea. Br J Dermatol. 1966;78:649-652.
4. McNeil BJ. Shattuck lecture-hidden barriers to improvement in the quality of care. N Engl J Med. 2001;345:1612-1620.
5. Bartholomew RS, Reid BJ, Cheesbrough MJ, et al. Oxytetracycline in the treatment of ocular rosacea: a double blind trial. Br J Ophthalmol. 1982;66:386-388.
6. Seal DV, Wright P, Ficker L, et al. Placebo controlled trial of fusidic acid gel and oxytetracycline for recurrent blepharitis and rosacea. Br J Ophthalmol. 1995;79:42-45.
7. Marmion VJ. Tetracyclines in the treatment of ocular rosacea. Proc R Soc Med. 1969;62:11-12.
8. Knight AG, Vickers CFH. A follow-up of tetracycline-treated rosacea; with special reference to rosacea keratitis. Br J Dermatol. 1975;93:577-580.
9. Frucht-Pery J, Chayet A, Feldman ST, et al. The effect of doxycycline on ocular rosacea. Am J Ophthalmol. 1989;107:434-435.
10. Frucht-Pery J, Sagi E, Hemo I, et al. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol. 1993;116:88-92.
11. Akpek EK, Merchant A, Pinar V, et al. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997;104:1863-1867.
12. Quarterman MJ, Johnson DW, Abele DC, et al. Ocular rosacea: signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997;133:49-54.
13. Jenkins MS, Brown SI, Lempert SL, et al. Ocular rosacea. Metab Pediatr Sys Ophthalmol. 1982;6:189-196.
14. Zengin N, Tol H, Gunduz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 1995;14:144-146.
15. Marks R, Ellis J. Comparative effectiveness of tetracycline and ampicillin in rosacea. Lancet. 1971;7733:1049-1052.
16. Nielsen PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol. 1983;109:63-65.
17. Saihan EM, Burton JL. A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol. 1980;102:443-445.
18. Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol. 1993;32:65-67.
19. Nielsen PG. The relapse rate for rosacea after treatment with either oral tetracycline or metronidazole cream. Br J Dermatol. 1983;109:122.
20. Torresani C, Pavesi A, Manara GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol. 1997;36:938-946.
21. Rufli T, Buchner SA. T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatologica. 1984;169:1-5.
22. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol. 2002;16:328-333.
23. Wedi B, Kapp A. Heliobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol. 2002;3:273-282.
24. Barton K, Monroy DC, Nava A, et al. Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology. 1997;104:1868-1874.
25. Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 2000;41:1703-1709.
26. Afonso AA, Sobrin L, Monroy DC, et al. Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci. 1999;40:2506-2512.
27. Sadowski T, Steinmeyer J. Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1. Inflamm Res. 2001;50:175-182.
28. Dougherty JM, McCulley JP, Silvany RE, et al. The role of tetracyclines in chronic blepharitis; inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci. 1991;32:2970-2975.
29. Shine WE, McCulley JP, Pandya AG. Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res. 2003;76:417-420.
30. Hoang-Xuan T, Rodriguez A, Zaltas MM, et al. Ocular rosacea. A histologic and immunopathologic study. Ophthalmology. 1990;97:1468-1475.
31. Kuzin II, Snyder JE, Ugine GD, et al. Tetracyclines inhibit activated B cell function. Int Immunol. 2001;13:921-931.
32. Farrell GC. Drug-induced hepatic injury. J Gastroenterol Hepatol. 1997;12:S242-S250.